tousled1
12-17-2007, 04:10 PM
SAN ANTONIO, Dec. 17 /PRNewswire/ -- A leading cancer physician and researcher affiliated with US Oncology Research, an established community-based research network specializing in Phase I - Phase IV cancer clinical trials, presented findings on a Phase II trial conducted to increase pathologic complete response (pCR) and discover a baseline tumor gene expression profile associated with subsequent pCR for patients with stage 2 and 3 breast cancer.
full article: http://www.earthtimes.org/articles/show/news_press_release,243535.shtml
full article: http://www.earthtimes.org/articles/show/news_press_release,243535.shtml